Your browser doesn't support javascript.
loading
Seroepidemiological and genomic investigation of SARS-CoV-2 spread in North East region of India.
Wahengbam, Romi; Bharali, Pankaj; Manna, Prasenjit; Phukan, Tridip; Singh, Moirangthem Goutam; Gogoi, Gayatri; Tapadar, Yasmin Begam; Singh, Anil Kumar; Konwar, Rituraj; Chikkaputtaiah, Channakeshavaiah; Velmurugan, Natarajan; Nagamani, Selvaraman; Mahanta, Hridoy Jyoti; Sarma, Himakshi; Sahu, Ravi Kumar; Dutta, Prachurjya; Wann, Sawlang Borsingh; Kalita, Jatin; Sastry, G Narahari.
Afiliação
  • Wahengbam R; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India. Electronic address: romiwahengbam@neist.res.in.
  • Bharali P; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Manna P; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Phukan T; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Singh MG; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Gogoi G; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
  • Tapadar YB; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
  • Singh AK; Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Konwar R; Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Chikkaputtaiah C; Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Velmurugan N; Branch Laboratory, CSIR-North East Institute of Science and Technology, Naharlagun, Papumpare, Arunachal Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Nagamani S; Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Mahanta HJ; Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Sarma H; Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
  • Sahu RK; Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Dutta P; Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
  • Wann SB; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Kalita J; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, 201002, India.
  • Sastry GN; Centre for Infectious Diseases, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Advanced Computation and Data Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India; Academy of Scientific and Innovative Research (AcSIR)
Indian J Med Microbiol ; 43: 58-65, 2023.
Article em En | MEDLINE | ID: mdl-36371334
ABSTRACT

PURPOSE:

Seroepidemiology and genomic surveillance are valuable tools to investigate infection transmission during a pandemic. North East (NE) India is a strategically important region being the gateway connecting the country with Southeast Asia. Here, we examined the spread of SARS-CoV-2 in NE India during the first and second waves of COVID-19 using serological and whole genome sequencing approaches.

METHODS:

qRT-PCR analysis was performed on a selected population (n â€‹= â€‹16,295) from June 2020 to July 2021, and metadata was collected. Immunoassays were studied (n â€‹= â€‹2026) at three-time points (August 2020, February 2021, and June 2021) and in a cohort (n â€‹= â€‹35) for a year. SARS-CoV-2 whole genomes (n â€‹= â€‹914) were sequenced and analyzed with those obtained from the databases.

RESULTS:

Test positivity rates (TPR) in the first and second waves were 6.34% and 6.64% in Assam, respectively, and a similar pattern was observed in other NE states. Seropositivity in the three time points was 10.63%, 40.3%, and 46.33%, respectively, and neutralizing antibody prevalence was 90.91%, 52.14%, and 69.30%, respectively. Persistence of pan-IgG-N SARS-CoV-2 antibody for over a year was observed among three subjects in the cohort group. Normal variants dominated the first wave, while B.1.617.2 and AY-sublineages dominated the second wave in the region. The prevalence of the variants co-related well with high TPR and seropositivity rate in the region and identified mostly among vaccinated individuals.

CONCLUSION:

The COVID-19 first wave in the region witnessed low transmission with the evolution of diverse variants. Seropositivity increased during the study period with over half of the individuals carrying neutralizing antibodies against SARS-CoV-2. High infection and seroprevalence in NE India during the second wave were associated with the dominant emergence of variants of concern.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Indian J Med Microbiol Assunto da revista: MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Indian J Med Microbiol Assunto da revista: MICROBIOLOGIA Ano de publicação: 2023 Tipo de documento: Article